DKSH has partnered with INFItech Limited (INFItech) to bring clinically-backed brain health supplements to consumers in Hong Kong and Macau. This exclusive agreement leverages DKSH’s extensive distribution network, industry expertise, and services to support INFItech’s expansion efforts in the region.
Hong Kong, May 12, 2025 – DKSH’s Business Unit Healthcare and INFItech, a Hong Kong-based consumer health company specializing in brain health supplements, enter a new strategic partnership that will bring INFItech’s innovative products to consumers in Hong Kong and Macau.
Under the agreement, DKSH will provide INFItech with services including sales promotion activities, distribution and logistics, as well as after-sales support to help the company expand its distribution reach through modern trade and e-commerce channels in these two markets.
Dr. Fanny Ip, Director of INFItech, commented: “We are excited to partner with DKSH, a market leader with a proven track record in consumer healthcare. DKSH’s expertise in product listing negotiations and promotional campaign execution will be invaluable as we seek to make our clinically-backed brain health products more widely available to consumers in these important markets.”
“This partnership underscores DKSH’s commitment to enriching people’s lives by providing better healthcare for all,” said Mr. Wai Ting Fong, Vice President, Healthcare, Hong Kong & Macau at DKSH. “As a strategic partner, we are patient-centric and look forward to leveraging our extensive distribution network, experience, and knowledge to drive the success of INFItech’s innovative brain health supplements in Hong Kong and Macau.”
The partnership with DKSH marks a new chapter for INFItech as it looks to expand the reach of its innovative brain health solutions and help more people safeguard their most precious memories.
About INFItech Limited
INFItech Limited was founded by a university research team specializing in neuroscience, with core technology licensed from a local university in Hong Kong in 2018. Based on over 20 years of extensive research on Chinese medicine, INFItech has been licensed to use patents and intellectual property licenses owned by the university, numerous research articles have been published in international journals. INFItech leverages the clinical experiences in using traditional Chinese medicinal herbs and screening by cutting-edge neuroscience drug discovery platforms for its Cogniherbs’ products. www.infitech.hk
About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter products and medical devices. With around 7,940 specialists, the Business Unit generated net sales of CHF 5.7 billion in 2024. www.dksh.com/hec